Evonik, one of the world’s leading specialty chemicals companies, has announced its intention to invest a further $15 million into its US operations in Virigina.
The investment plan entails the creation of a new ‘business and innovation centre’, which will give rise to 50 additional jobs in the next five years, increasing Evonik’s workforce by nearly a third.
“This investment will enable Evonik to expand its current operations in the Greater Richmond area and preserve more than 130 jobs,” said Dr. Reinhold Brand, senior vice president and general manager of Evonik's Consumer Specialties unit in North America.
Brand stated that the investment and subsequent develppment will open up entrepreneurial opportunities for the chemicals manufacturer.
“With the new facility, Evonik doubles its laboratory space in Virginia, providing the opportunity to undertake special research and development projects including joint operative research for customers,” he said.
The development will be made on a 93,000 square foot facility in Chesterfield, Greater Richmond, which was recently acquired by the company.